ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

266. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated centralvenous [correction of nervous] catheter. Anesthesiology 1997; 87:1242?4.267. Pittaway A, Ford S. Allergy to chlorhexidine-coated central venous catheters revisited. Br J Anaesth 2002;88:304?5; author reply 305.268. Stephens R, Mythen M, Kallis P, Davies DW, Egner W, Rickards A. Two episodes of life-threateninganaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter. Br JAnaesth 2001; 87:306?8.269. Terazawa E, Shimonaka H, Nagase K, Masue T, Dohi S. Severe anaphylactic reaction due to achlorhexidine-impregnated central venous catheter. Anesthesiology 1998; 89:1296?8.270. Jee R, Nel L, Gnanakumaran G, Williams A, Eren E. Four cases of anaphylaxis to chlorhexidineimpregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth 2009;103:614?5.271. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous cathetersfor the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554?60.272. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance toantiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47:589?98.273. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antisepticsor antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. InfectControl Hosp Epidemiol 2001; 22:640?6.274. Marciante KD, Veenstra DL, Lipsky BA, Saint S. Which antimicrobial impregnated central venous cathetershould we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 2003;31:1?8.275. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters: potential financialimplications. Chest 2003; 124:275?84.276. Hagau N, Studnicska D, Gavrus RL, Csipak G, Hagau R, Slavcovici AV. Central venous cathetercolonization and catheter-related bloodstream infections in critically ill patients: a comparison betweenstandard and silver-integrated catheters. Eur J Anaesthesiol 2009; 26:752?8.277. Bong JJ, Kite P, Wilco MH, McMahon MJ. Prevention of catheter related bloodstream infection by silveriontophoretic central venous catheters: a randomized controlled trial.J Clin Pathol 2003; 56:731?5.278. Corral L, Nolla-Salas M, Ibanez-Nolla J, et al. A prospective, randomized study in critically ill patients usingthe Oligon Vantex catheter. J Hosp Infect 2003; 55:212?9.279. Ranucci M, Isgro G, Giomarelli PP, et al. Impact of oligon central venous catheters on catheter colonizationand catheter-related bloodstream infection. Crit Care Med 2003; 31:52?9.280. Raad II, Hachem RY, Abi-Said D, et al. A prospective crossover randomized trial of novobiocin and rifampinprophylaxis for the prevention of intravascular catheter infections in cancer patients treated withinterleukin-2. Cancer 1998; 82:403?11.281. McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertionreduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985; 6:419?25.282. Sandoe JA, Kumar B, Stoddart B, et al. Effect of extended perioperative antibiotic prophylaxis onintravascular catheter colonization and infection in cardiothoracic surgery patients. J Antimicrob Chemother2003; 52:877?9.283. Inglis GDT, Jardine LA, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in neonateswith umbilical artery catheters. Cochrane Database of Systematic Reviews 2007; Issue 4. Art. No.:CD004697. DOI: 10.1002/14651858.CD004697.pub3.63